Back

Long-term clinical benefit of atorvastatin pretreatment before primary percutaneous coronary intervention in patients with STEMI: a multi-center propensity score-matched study

31 August 2019 (11:00 - 16:00)
Organised by:
Congress Presentation Part of: Poster Session 1 - Acute coronary syndromes, coronary artery disease: treatment Pharmacotherapy ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Jin-Gang Yang

National Center for Cardiovascular Diseases, Beijing (China)

16 More presentations in this session

Presentation thumbnail
Doctor K. Svendsen (Oslo, NO)
Abstract Slides
Presentation thumbnail
Doctor R. CHEN (Beijing, CN)
Abstract Slides
Presentation thumbnail
Associate Professor K. Dyrbus (Zabrze, PL)
Abstract Slides
Presentation thumbnail
Doctor A. Mahabadi (Essen, DE)
Abstract
Presentation thumbnail
Doctor C. Kissel (Zurich, CH)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 1 - Acute coronary syndromes, coronary artery disease: treatment

The Event

Event poster

ESC Congress 2019

31 August 2019 11:00 CET
You may be interested in
thumbnail
Congress Presentation
STEMI antiplatelet pretreatment strategy - national multicenter registry experience
9 March 2024
thumbnail
Congress Presentation
Statins for secondary prevention of coronary artery disease in patients aged 80 years or older: a nation-wide propensity score-based analysis
26 April 2024
thumbnail
Congress Presentation
The incidence of muscle tissue damage during therapy with atorvastatin in patients after STEMI
27 August 2021
thumbnail
Congress Presentation
Effect and safety of PCSK9 inhibitor in-hospital use on blood lipid level in the ACS patients: a systematic review and meta-analysis
13 April 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources